Geron
GERN
A$2.18
Share price
2.14%
Change (1 day)
-66.44%
Change (1 year)
Categories
Geron (GERN) - Total debt
Total debt on the balance sheet as of March 2025 : A$0.18 Billion
According to Geron's latest financial reports the company's total debt is A$0.18 Billion. A company’s total debt is the sum of all current and non-current debts.
Geron - Total debt on balance sheet (from 1996 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | A$0.19 B | 55.21% |
| 2023-12-31 | A$0.12 B | 53.89% |
| 2022-12-31 | A$81.92 M | 8% |
| 2021-12-31 | A$75.86 M | 96.28% |
| 2020-12-31 | A$38.64 M | 959.53% |
| 2019-12-31 | A$3.64 M | |
| 2018-12-31 | N/A | |
| 2005-12-31 | A$0.07 M | -98.21% |
| 2004-12-31 | A$4.19 M | -49.65% |
| 2003-12-31 | A$8.32 M | -81.97% |
| 2002-12-31 | A$46.18 M | 35.33% |
| 2001-12-31 | A$34.13 M | -42.79% |
| 2000-12-31 | A$59.66 M | 114.24% |
| 1999-12-31 | A$27.84 M | 89.47% |
| 1998-12-31 | A$14.69 M | 316.36% |
| 1997-12-31 | A$3.53 M | 0.16% |
| 1996-12-31 | A$3.52 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Eterna Therapeutics ERNA | A$4.38 M | -97.63% | 🇺🇸 USA |
 Gilead Sciences GILD | A$37.96 B | 20,389.74% | 🇺🇸 USA |
 Bio-Techne TECH | A$0.64 B | 247.76% | 🇺🇸 USA |
 Incyte INCY | A$65.6 M | -64.59% | 🇺🇸 USA |
 CTI BioPharma
CTIC | A$74.38 M | -59.85% | 🇺🇸 USA |